vs

Side-by-side financial comparison of Aterian, Inc. (ATER) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $14.7M, roughly 1.0× IRIDEX CORP). On growth, Aterian, Inc. posted the faster year-over-year revenue change (-38.5% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -13.5%).

Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

ATER vs IRIX — Head-to-Head

Bigger by revenue
ATER
ATER
1.0× larger
ATER
$15.1M
$14.7M
IRIX
Growing faster (revenue YoY)
ATER
ATER
+31.2% gap
ATER
-38.5%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-13.5%
ATER

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATER
ATER
IRIX
IRIX
Revenue
$15.1M
$14.7M
Net Profit
$-7.9M
Gross Margin
56.1%
37.2%
Operating Margin
-51.1%
Net Margin
-52.5%
Revenue YoY
-38.5%
-69.7%
Net Profit YoY
-512.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATER
ATER
IRIX
IRIX
Q4 25
$15.1M
$14.7M
Q3 25
$19.0M
$12.5M
Q2 25
$19.5M
$13.6M
Q1 25
$15.4M
$11.9M
Q4 24
$24.6M
$12.7M
Q3 24
$26.2M
$11.6M
Q2 24
$28.0M
$12.6M
Q1 24
$20.2M
$11.8M
Net Profit
ATER
ATER
IRIX
IRIX
Q4 25
$-7.9M
Q3 25
$-2.3M
$-1.6M
Q2 25
$-4.9M
$-994.0K
Q1 25
$-3.9M
$-1.7M
Q4 24
$-1.3M
$-834.0K
Q3 24
$-1.8M
$-1.9M
Q2 24
$-3.6M
$-2.7M
Q1 24
$-5.2M
$-3.5M
Gross Margin
ATER
ATER
IRIX
IRIX
Q4 25
56.1%
37.2%
Q3 25
56.1%
32.1%
Q2 25
54.3%
34.5%
Q1 25
61.4%
42.5%
Q4 24
63.4%
44.0%
Q3 24
60.3%
37.3%
Q2 24
60.4%
40.7%
Q1 24
65.1%
37.9%
Operating Margin
ATER
ATER
IRIX
IRIX
Q4 25
-51.1%
Q3 25
-10.7%
-11.3%
Q2 25
-23.1%
-6.9%
Q1 25
-24.1%
-1.7%
Q4 24
-6.5%
-3.9%
Q3 24
-6.6%
-16.1%
Q2 24
-11.5%
-20.9%
Q1 24
-26.1%
-28.0%
Net Margin
ATER
ATER
IRIX
IRIX
Q4 25
-52.5%
Q3 25
-12.0%
-12.6%
Q2 25
-25.0%
-7.3%
Q1 25
-25.4%
-14.2%
Q4 24
-5.3%
-6.6%
Q3 24
-6.8%
-16.7%
Q2 24
-13.0%
-21.2%
Q1 24
-25.5%
-29.5%
EPS (diluted)
ATER
ATER
IRIX
IRIX
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATER
ATER
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$4.9M
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.2M
Total Assets
$29.6M
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATER
ATER
IRIX
IRIX
Q4 25
$4.9M
$6.0M
Q3 25
$7.6M
$5.6M
Q2 25
$10.5M
$6.8M
Q1 25
$14.3M
$7.2M
Q4 24
$18.0M
$2.4M
Q3 24
$16.1M
$3.9M
Q2 24
$20.3M
$4.1M
Q1 24
$17.5M
$5.4M
Total Debt
ATER
ATER
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
ATER
ATER
IRIX
IRIX
Q4 25
$15.2M
Q3 25
$22.6M
$4.7M
Q2 25
$24.3M
$6.1M
Q1 25
$27.0M
$852.0K
Q4 24
$30.0M
$2.1M
Q3 24
$30.6M
$2.6M
Q2 24
$30.9M
$4.2M
Q1 24
$33.0M
$6.5M
Total Assets
ATER
ATER
IRIX
IRIX
Q4 25
$29.6M
$29.2M
Q3 25
$40.1M
$28.4M
Q2 25
$45.4M
$31.6M
Q1 25
$49.8M
$34.2M
Q4 24
$49.5M
$29.1M
Q3 24
$52.1M
$30.2M
Q2 24
$59.9M
$31.2M
Q1 24
$55.7M
$34.1M
Debt / Equity
ATER
ATER
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATER
ATER
IRIX
IRIX
Operating Cash FlowLast quarter
$-1.0M
Free Cash FlowOCF − Capex
$-1.0M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATER
ATER
IRIX
IRIX
Q4 25
$-1.0M
Q3 25
$-1.6M
$-1.2M
Q2 25
$-4.4M
$-397.0K
Q1 25
$-3.9M
$-1.1M
Q4 24
$-9.0K
$-1.2M
Q3 24
$-722.0K
$-3.1M
Q2 24
$2.9M
$-1.3M
Q1 24
$-6.0K
$-1.6M
Free Cash Flow
ATER
ATER
IRIX
IRIX
Q4 25
$-1.0M
Q3 25
$-1.6M
$-1.2M
Q2 25
$-4.4M
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
$2.9M
Q1 24
$-42.0K
$-1.7M
FCF Margin
ATER
ATER
IRIX
IRIX
Q4 25
-6.9%
Q3 25
-8.4%
-9.4%
Q2 25
-22.7%
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
10.3%
Q1 24
-0.2%
-14.0%
Capex Intensity
ATER
ATER
IRIX
IRIX
Q4 25
0.0%
Q3 25
0.2%
0.1%
Q2 25
0.0%
0.1%
Q1 25
0.0%
0.1%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.0%
Q1 24
0.2%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATER
ATER

Sales Channel Directly To Consumer$13.1M87%
Heating Cooling And Air Quality$2.1M14%

IRIX
IRIX

Segment breakdown not available.

Related Comparisons